NNC-45-0095 is a synthetic nonsteroidal selective estrogen receptor modulator which was under development by Novo Nordisk for the treatment of postmenopausal osteoporosis but was never marketed.
MedKoo Cat#: 414443
Name: NNC-45-0095
CAS#: 217318-90-6
Chemical Formula: C18H15NO
Exact Mass: 261.1154
Molecular Weight: 261.32
Elemental Analysis: C, 82.73; H, 5.79; N, 5.36; O, 6.12
The following data is based on the product molecular weight 261.32 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
